University of Toronto: New Cancer Treatment Slows Aggressive Neuroendocrine Tumours
July 03, 2024
July 03, 2024
TORONTO, Ontario, July 3 (TNSres) -- The University of Toronto issued the following news:
By Nadia Radovini
A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumour progression and death, according to research led by scientists at Sunnybrook Health Sciences Centre and the University of Toronto.
Results of the multi-centre clinical trial, which were publis . . .
By Nadia Radovini
A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumour progression and death, according to research led by scientists at Sunnybrook Health Sciences Centre and the University of Toronto.
Results of the multi-centre clinical trial, which were publis . . .